Stay updated on Fazirsiran Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the Fazirsiran Safety & Efficacy Clinical Trial page.

Latest updates to the Fazirsiran Safety & Efficacy Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe webpage has been updated to include new information about the clinical study AROAAT2001 (SEQUOIA), including details about the investigational product Fazirsiran and its administration to participants with alpha-1 antitrypsin deficiency. Additionally, the page now features a disclaimer regarding the U.S. government's review of studies listed on the site.SummaryDifference100%
- Check21 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check29 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.7%
- Check37 days agoChange DetectedThe web page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about HHS Vulnerability Disclosure.SummaryDifference0.1%
- Check44 days agoChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference0.1%
- Check51 days agoChange DetectedA service alert has been added regarding planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.SummaryDifference0.7%
Stay in the know with updates to Fazirsiran Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fazirsiran Safety & Efficacy Clinical Trial page.